Skip to main content

Effective Hypertension Management

A Qualitative Study on the Barriers and Enablers to Effective Hypertension Management


Background:


Hypertension remains a significant public health challenge in Ghana. Understanding the experiences of hypertensive patients can inform strategies to improve their management. This study explored the perceived enablers and barriers to hypertension management among patients in the Ashanti region, Ghana, using the Chronic Care Model as a framework.

Methods:


In-depth interviews were conducted with 20 hypertensive patients receiving care at Komfo Anokye Teaching Hospital. Inductive thematic analysis was employed to identify key themes and subthemes.

Results:


Several barriers to hypertension management emerged, including economic constraints, environmental and lifestyle factors, knowledge and awareness deficits, medication-related issues, and policy and provider-level barriers. Conversely, enablers such as patient empowerment, education, healthcare access, and policy and provider support and relationships were identified.

Conclusions:


Effective hypertension management requires addressing a complex interplay of barriers and enablers. Interventions targeting economic factors, lifestyle modifications, knowledge dissemination, medication adherence, and systemic improvements are crucial. Additionally, empowering patients, enhancing education, improving healthcare access, and fostering strong provider–patient relationships can significantly contribute to better outcomes. Future research should investigate the impact of a multi-level intervention on hypertension management in Ghana.

Blood RNA, transcriptomics, gene expression, liquid biopsy, RNA sequencing, blood biomarkers, non-coding RNA, mRNA profiling, RNA stability, exosomal RNA, RNA extraction, RNA-based diagnostics, circulating RNA, lncRNA, microRNA, gene signatures, RNA quantification, RNA-Seq data, whole blood transcriptome, molecular profiling

#BloodRNA, #Transcriptomics, #GeneExpression, #LiquidBiopsy, #RNASequencing, #Biomarkers, #NonCodingRNA, #mRNAProfiling, #ExosomalRNA, #RNADiagnostics, #CirculatingRNA, #lncRNA, #miRNA, #GeneSignature, #RNAQuantification, #RNASeq, #MolecularBiology, #BloodBiomarkers, #TranscriptomeAnalysis, #PrecisionMedicine

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more